logo
  • 中国高校优秀科技期刊
  • 中国高校特色科技期刊
  • 中国核心期刊(遴选)数据库收录期刊
  • 中国AMI综合评价职院刊扩展期刊
  • RCCSE高职高专院校学报类核心期刊

盐酸头孢吡肟与精氨酸共沉淀行为研究

马金菊, 王振强, 刘伟

马金菊, 王振强, 刘伟. 盐酸头孢吡肟与精氨酸共沉淀行为研究[J]. 黄河水利职业技术学院学报, 2017, 29(3): 51-54. DOI: 10.13681/j.cnki.cn41-1282/tv.2017.03.013
引用本文: 马金菊, 王振强, 刘伟. 盐酸头孢吡肟与精氨酸共沉淀行为研究[J]. 黄河水利职业技术学院学报, 2017, 29(3): 51-54. DOI: 10.13681/j.cnki.cn41-1282/tv.2017.03.013
Ma Jinju, Wang Zhenqiang, Liu Wei. Study on Coprecipitation of Cefepime hydrochloride and Arginine[J]. Journal of Yellow River Conservancy Technical Institute, 2017, 29(3): 51-54. DOI: 10.13681/j.cnki.cn41-1282/tv.2017.03.013
Citation: Ma Jinju, Wang Zhenqiang, Liu Wei. Study on Coprecipitation of Cefepime hydrochloride and Arginine[J]. Journal of Yellow River Conservancy Technical Institute, 2017, 29(3): 51-54. DOI: 10.13681/j.cnki.cn41-1282/tv.2017.03.013

盐酸头孢吡肟与精氨酸共沉淀行为研究

详细信息
    作者简介:

    马金菊(1985-),女,河南南阳人,助教,硕士,主要从事高校生物化工专业的教学与研究工作,研究方向为药物稳定性技术。

  • 中图分类号: TQ465.1

Study on Coprecipitation of Cefepime hydrochloride and Arginine

  • 摘要: 通过改变盐酸头孢吡肟和L-精氨酸的摩尔比,采用共沉淀的方法制备出了一系列组合物,利用高效液相色谱(HPLC)、红外光谱(IR)和X射线粉末衍射(XRPD)等技术对产品的组成及结晶情况进行了研究,结果显示:在采用共沉淀方法制备的组合物中,盐酸头孢吡肟和精氨酸的摩尔比与投料的摩尔比基本相同,即得到的共沉淀产品为固体溶液,而不是共晶。均一度测试表明,以各种投料比制备的产品均匀性均优于市售物理混合产品。
    Abstract: By changing the mole ratios of Cefepime hydrochloride and L-Arginine,using the coprecipitation method,it prepares a series of compositions.The composition and the crystal mophology of were studied by High Performance Liquid Chromatography(HPLC),Infrared spectroscopy(IR),X-Ray Power Diffraction(XRPD).The results showed that mole ratios of Cefepime hydrochloride and L-arginine in the coprecipitation product were the same as the feeding molar ratio,which declared that coprecipitation product were solid solution,rather than cocrystal.It turned out that the uniformity of the coprecipitation product was higher than that of the commercial product.
  • [1] 弋东旭,洪鸣凰,徐军,等.药物共晶研究进展及应用[J].中国抗生素杂志,2011,36(8):561-565.
    [2] 易涵,尹亚妹,赵秀丽,等.伊曲康唑共晶的制备与表征[J].沈阳药科大学学报,2014(3):161-168.
    [3] 王义成,冯成亮,杨素勤,等.药物共晶的最新研究进展[J].药学进展,2013,37(3):120-130.
    [4]

    Stahly G P.Diversity in single-and multiple-component crystals.The search for and prevalence of polymorphs and cocrystals[J].Cryst Growth Des,2007,7(6):1007-1026.

    [5]

    Son S F,A say B,Busse J R,et al.Reaction propagation of Al/MoO3 nanocomposite thermites[A].Proceedings of the International Pyrotechnics Seminar[C].28th.2001,833-843.

    [6] 杨永明,张建国.LAN系共沉淀起爆药的制备工艺与性能研究[J].含能材料,2001,9(3):107-110.
    [7]

    Aisawa S,Takahashi S,Ogasawara WYNarita E.Direct intercalation of amino acids into layered double hydroxides by coprecipitation[J].Solid State Chem.,2001,162(1):52-62.

    [8]

    Bristol-Myers Company.Cefepime cephalosporin salts:U.S.Patent,4,910,301[P].1990-03-20.

    [9]

    Bristol-MyersCompany.Cephalosporinsaltsandinjectable compositions,U.S.Patent,4,994,451[P].1991-02-19.

    [10]

    Bristol-Myers Squibb Company.Injectable compositions ofcefepimedihydrochloridehydrate:U.S.Patent,5,244,891[P].1993-09-14.

    [11]

    Bristol-MyersCompany.Lyophilizedorprecipitated cephalosporinzwitterionandsaltcombination:U.S.Patent,4,808,617[P].1989-02-28.

    [12]

    Lupin Ltd(IN),Tyagi OM Dutt(IN),Chauhan Yogendra Kumar(IN),Srivastava Tushar Kumar(IN).A co-precipitated cefepime composition and process for preparation thereof.WO2005IN00095[P].2005-10-13.

计量
  • 文章访问数:  14
  • HTML全文浏览量:  0
  • PDF下载量:  1
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-03-20

目录

    /

    返回文章
    返回